Description

Depakin (sodium valproate) syrup 150 ml

Ingredients

Active ingredient: Sodium valproate

Dosage

Recommended dosage: As directed by a healthcare professional.

Indications

Depakin syrup is indicated for the treatment of epilepsy and bipolar disorder.

Contraindications

Do not use Depakin syrup if:

• You are allergic to sodium valproate or any other ingredients in the syrup.
• You have a history of liver problems.
• You are pregnant or breastfeeding without medical advice.

Directions

Shake well before use. Take the prescribed amount orally, with or without food, as directed by your healthcare provider.

Scientific Evidence

Depakin (sodium valproate) has been extensively studied for its efficacy in managing epilepsy and bipolar disorder. Research published in the Journal of Clinical Psychopharmacology demonstrated the effectiveness of sodium valproate in controlling manic episodes in patients with bipolar disorder.

Additional Information

It is important to follow the prescribed dosage and frequency of Depakin syrup to achieve optimal therapeutic effects. Regular monitoring of liver function tests is recommended during treatment with sodium valproate.

Pharmacological Effects: Sodium valproate works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, which has inhibitory effects, thereby reducing abnormal electrical activity that leads to seizures in epilepsy.

Clinical Trials: A randomized controlled trial published in the New England Journal of Medicine compared the efficacy of sodium valproate with other antiepileptic drugs and found it to be equally effective in controlling seizures with a favorable side effect profile.